The calcium-binding protein S100A16 may contribute to the poor prognosis of RCC by boosting renal cell carcinoma development and angiogenesis through the VEGF/VEGFR2 signaling pathway. The gene discussed is VEGFA; the disease is renal cell adenocarcinoma.